ADVERTISEMENT

Elections

Gloomy Forecast For Cultivation Of Additional Hemp Legislation In Next Congress

“I think the Republican Congress is going to slow down all of what's called progress, for lack of a better word, toward having hemp be accessible to folks in all kinds of forms,” says Doug Gansler, former Maryland state AG and chair of Cadwalader, Wickersham & Taft LLP’s state AG practice.

Finance Watch: Biopharma Stocks Sink On RFK Jr. Nomination To Head HHS

Public Company Edition: President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to lead the US Department of Health and Human Services is seen as raising the potential for regulatory risk. Also, Geron revealed up to $375m in royalty and debt financings, while Zai Lab grossed $200m in a FOPO.

Industry Support Key To US FDA’s Prospects Under Trump – Califf

The FDA's current leader, whose term will end with Donald Trump’s second inauguration, also described three qualities the agency’s next commissioner will need to succeed, including "believing that there is such a thing as expertise."

Industry Support Key To US FDA’s Prospects Under Trump, Califf Says

The FDA's current leader, whose term will end with Donald Trump’s second inauguration, also described three qualities the agency’s next commissioner will need to succeed, including "believing that there is such a thing as expertise."

Asking For More: Supplement MPL Authority For FDA, Agency Results For Congress, Industry

Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.

2024 US Presidential Election: Implications For Beauty Industry

The US' approach to international trade and potential for new tariffs on China or other partners could be the most significant issue for the beauty industry ahead of the presidential election in November, experts suggested at the Independent Beauty Association’s Cosmetics Convergence Fall 2024 Symposium.

Fresh From The CHPA Regulatory Conference Stage

In addition to commentary and information about the OTC drug, dietary supplement and cosmetic industries, speakers offered candid remarks on subjects well known across the consumer health industry or well recognized by consumers.

US Presidential Elections: Are Prescription Drug Pricing Reforms Losing Political Luster?

Neither Kamala Harris nor Donald Trump mentioned drug pricing reforms in their presidential convention speeches.

FDA Disruption: If Trump Wins, Could Big Changes Be Coming?

The agency is clearly on the radar of former President Trump and his new coterie of tech moguls.

People On The Move: Appointments At Gilbert, ProBiotix, EU Parliament

A round-up of the latest appointments across Europe's health and wellness markets: France's Gilbert appoints managing director; ProBiotix names marketing head; European Parliament elects committee chairs.